Panagora Asset Management Inc Paratek Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$4.7 - $7.24 $2,702 - $4,163	-575 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$6.81 - $10.93 $15,880 - $25,488	-2,332 Reduced 80.22%	575 $4,000
Q4 2020 Feb 10, 2021	BUY	$4.58 - $7.14 $7,021 - $10,945	1,533 Added 111.57%	2,907 $18,000
Q3 2020 Nov 13, 2020	BUY	$4.19 - $6.69 $5,757 - $9,192	1,374 New	1,374 $7,000
Q4 2017 Feb 14, 2018	SELL	$17.45 - $25.6 $858,452 - $1.26 Million	-49,195 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $929,785 - $1.39 Million	49,195	49,195 $1.24 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.